Mobix Labs has filed a preliminary prospectus supplement under its existing Form S-3 shelf registration statement (File No. 333-284351), declared effective January 24, 2025, signaling its intent to offer new shares of common stock (or equivalents) in a firm public offering. D. Boral Capital LLC is acting as sole placement agent. Net proceeds are earmarked for working capital and general corporate purposes, enhancing liquidity to support research, development and strategic initiatives. The offering remains subject to market conditions with no assurance as to timing, size or terms, and interested investors are directed to review the full preliminary prospectus on the SEC’s website for comprehensive risk disclosures and use-of-proceeds details.

Mobix Labs has named Amir Asvadi as General Manager of its EMI product line and defense manufacturing operations, leveraging his prior leadership roles at publicly traded defense and aerospace firms such as Microsemi. Concurrently, the company plans to relocate West Coast operations into a larger, military-approved production facility designed to consolidate engineering, manufacturing and administrative functions under one roof. This expansion aims to double current throughput capacity and streamline delivery cycles for mission-critical components used in platforms including the U.S. F-35 Lightning II, F/A-18 Super Hornet, F-22 Raptor, MH-47 Chinook and Apache helicopter. Management expects the combined leadership reinforcement and facility upgrade to bolster operational efficiency, support growing defense demand and reinforce the company’s position in high-reliability connectivity markets.